Everolimus-Eluting Platinum Chromium Coronary Stent System
PLATINUM Workhorse Trial
Evaluate the safety and effectiveness of the Promus PtCr EES Coronary Stent System* for the treatment of patients with up to 2 de novo lesions ≤ 24 mm in length; ≥ 2.50 mm to ≤ 4.25 mm in diameter compared to the Xience CoCr EES.
Prospective, Randomized, Controlled, Non-inferiority, Multicenter
Numerically Lower Ischemia-Driven TLR Through 5 Years2
Numerically Lower Event Rate Through 5 Years2
Outstanding Safety Shown in Real-World Use
Kang Network Meta-Analysis3
Enhanced delivery system for the optimal balance of pushability, flexibility and trackability.